Watertown, MA, United States of America

Bu Wang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bu Wang

Introduction

Bu Wang is a notable inventor based in Watertown, MA (US). He has made significant strides in the field of biomolecular delivery, particularly in methods that induce tolerance to antigens. His work is crucial for advancing therapeutic approaches in immunology.

Latest Patents

Bu Wang holds a patent for "Intracellular delivery of biomolecules to induce tolerance." This invention provides methods for inducing tolerance and suppressing an immune response to an antigen by passing a cell suspension containing an anucleate cell through a constriction. The constriction deforms the cell, causing a perturbation that allows an antigen and/or tolerogenic factor to enter the cell. In certain embodiments, the anucleate cell is delivered to an individual, and the antigen is processed in a tolerogenic environment to induce tolerance and suppress the immune response.

Career Highlights

Bu Wang is currently associated with Stemcell Technologies Canada Inc., where he continues to innovate in the field of cellular biology. His work has the potential to impact various therapeutic applications, particularly in treating autoimmune diseases and enhancing transplant acceptance.

Collaborations

Some of his notable coworkers include Jonathan B Gilbert and Scott Loughhead, who contribute to the collaborative environment that fosters innovation at Stemcell Technologies Canada Inc.

Conclusion

Bu Wang's contributions to the field of biomolecular delivery and immunology are significant, showcasing his dedication to advancing medical science. His patent on inducing tolerance through innovative methods highlights the potential for new therapeutic strategies in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…